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V WF (von Willebrand factor) is a large multimeric protein that plays an important role in hemostasis and thrombosis. VWF is stored as ultra large (ultra large VWF) multimers or high molecular weight multimers in endothelial Weibel-Palade bodies and platelet α-granules. 1 On secretion into circulation and under shear stress, anchored hyperactive ultra large VWF multimers on the endothelium are cleaved by ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type I repeats-13) into smaller less active VWF multimers that support hemostasis and thrombosis. 2 VWF present in plasma is derived from both endothelial cells (≈80%-85% via a constitutive secretory pathway or regulated secretion in response to secretagogues, such as tumor necrosis factor and histamine) and platelets (≈15%-20% from activated platelets). 3, 4 Several murine studies suggest that VWF/ADAMTS13 axis modulates vascular inflammation in addition to thrombosis in experimental models. [5] [6] [7] [8] [9] [10] [11] [12] [13] For example, ADAMTS13 deficiency in mice exacerbates myocardial and brain ischemia/ reperfusion injury by promoting thrombosis and inflammatory processes, 7, 8, 11, 14 whereas VWF deficiency had a protective effect. 7, 11, 14, 15 Similarly, ADAMTS13 deficiency in mice exacerbates atherosclerosis, 9, 10, 16 whereas VWF deficiency reduces atherosclerosis in mice and pigs. 9, 12, 17 Although the role of VWF in atherosclerosis is well established, the relative contribution of platelet-derived VWF (Plt-VWF) versus endothelial cellderived VWF (EC-VWF) in atherosclerotic lesion progression is not yet elucidated. Notably, several in vitro studies suggest that there are biochemical and functional differences between Plt-VWF and EC-VWF. For example, Plt-VWF differs in glycosylation profile, particularly with a reduction in N-linked sialic acid expression when compared with EC-VWF. 18 Although platelets contain ADAMTS13, the authors suggested that because of different glycosylation profile, Plt-VWF is resistant to ADAMTS13 cleavage. 18 In contrast, other in vitro studies have shown that platelet-derived ultra large VWF multimers are only observed when platelets are activated or lysed in the presence of EDTA. 19, 20 There is also a functional difference between EC-VWF and Plt-VWF. Although binding affinities to collagen are comparable between EC-VWF and Plt-VWF, Plt-VWF binds with higher affinity to the surface of thrombin-stimulated platelets when compared with EC-VWF. 21, 22 However, EC-VWF binds with higher affinity to platelet GPIbα (glycoprotein Ib) when compared with Plt-VWF. 22 Herein, we sought to determine the relative contribution of Plt-VWF versus EC-VWF pool in the pathophysiology of atherosclerosis. Using reciprocal bone marrow (BM) transplantation, we generated chimeric Plt-VWF and EC-VWF mice on the apolipoprotein E (Apoe)-deficient background. We found that EC-VWF, but not Plt-VWF, contributes to atherosclerotic lesion progression by promoting platelet adhesion and vascular inflammation.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. −/− mice (ADAMTS13 deficient in plasma and platelet plus lack VWF in endothelial cells; Figure 1A ). Complete blood counts were comparable suggesting that BM transplantation did not affect the number of BM-derived blood cells (Table I in the online-only Data Supplement). To confirm successful engraftment of BM, the relative content of VWF in plasma and platelets was quantified by ELISA. Plasma VWF levels were comparable between WT mice (414.5±53.5%) and EC-VWF mice (439.9±29.0%; Figure 1B) . Notably, plasma VWF levels in Apoe −/− mice are relatively higher to WT levels. No detectable levels of plasma VWF were found in VWF-KO mice, whereas a minor amount of plasma VWF ( Figure 1B ) was found in Plt-VWF (6.7±1.1%) and Plt-VWF/ADAMTS13 −/− mice (5.6±0.9%). Plt-VWF levels were comparable between WT, Plt-VWF mice and Plt-VWF/ ADAMTS13 −/− mice ( Figure 1C ). No detectable level of Plt-VWF was found in VWF-KO or EC-VWF mice ( Figure 1C ).
Results

Characterization of Chimeric Mice Expressing Plt-VWF and EC-VWF on
EC-VWF, But Not Plt-VWF, Exacerbates Atherosclerosis in Aorta and Aortic Sinus
To define the relative contribution of Plt-VWF versus EC-VWF pool in the pathophysiology of atherosclerosis, EC-VWF and Plt-VWF female mice with controls (WT and VWF-KO) were fed a high-fat Western diet for 14 weeks. We measured total cholesterol and triglyceride levels in all the groups fed a high-fat Western diet for 14 weeks. Total cholesterol and triglyceride levels were comparable among groups ( Figure I in the online-only Data Supplement). Next, we compared the extent of atherosclerotic lesion progression in whole aortae by staining with Oil Red O and quantifying en face lesion area. Lesion areas were comparable between EC-VWF (22.8±2.3%) and WT mice (21.8±1.8%; Figure 2A and 2B). Similar to previous reports, 9, 12 VWF-KO mice exhibited significantly reduced lesions area (12.7±1.1%; P<0.05) when compared with either EC-VWF or WT mice. Atherosclerotic lesion area was comparable between Plt-VWF (14.7±1.3%) and VWF-KO mice (Figure 2A and 2B) . These results suggest that EC-VWF, but not Plt-VWF, contributes to accelerated atherosclerosis in the aorta. Next, we determined whether Plt-VWF, in the absence of ADAMTS13 in plasma and platelets, is able to promote atherosclerosis comparable to EC-VWF. Lesion areas were comparable in Plt-VWF mice (14.7±1.3%) and Plt-VWF/ADAMTS13 −/− mice (11.4±1.0%) but significantly decreased when compared with WT mice (21.8±1.8%) or EC-VWF mice (22.8±2.3%; P<0.05; Figure 2A and 2B). This result suggests that Plt-VWF even in the absence of ADAMTS13 was not sufficient to promote atherosclerosis similar to EC-VWF.
Next, we quantified the cross-sectional area of atherosclerotic lesions in the aortic sinus using the VerHoeffs/Van Gieson staining method. We found that the mean lesion areas (in μm 2 or %) in the aortic sinus were comparable between VWF-KO (29.5±2.2%), Plt-VWF (33.2±1.8%), and Plt-VWF/ ADAMTS13 −/− mice (29.3±1.6%) but significantly decreased Figure 3A -3C). Furthermore, necrotic area (unstained acellular area, %) was comparable between VWF-KO, Plt-VWF, and Plt-VWF/ADAMTS13 −/− mice but significantly decreased when compared with EC-VWF or WT mice (P<0.05; Figure 3D ).
EC-VWF, But Not Plt-VWF, Promotes Vascular Inflammation in Aortic Sinus of Apoe −/− Mice
To test the hypothesis that EC-VWF promotes vascular inflammation within atherosclerotic lesions, we quantitated macrophage and neutrophil infiltration within lesions in the aortic sinus by immunohistochemistry. We found that the Mac-3-positive areas (μm 2 ) were comparable between VWF-KO, Plt-VWF, and Plt-VWF/ADAMTS13
−/− mice but significantly decreased when compared with EC-VWF or WT mice (P<0.05; n=10-12 mice/group; Figure 4A ). Not only was the absolute Mac-3-positive area increased in EC-VWF and WT mice ( Figure II in the online-only Data Supplement) but also the percent of the total lesion area occupied by Mac-3-positive cells was also significantly higher in EC-VWF or WT mice when compared with VWF-KO or Plt-VWF or Plt-VWF/ADAMTS13 −/− mice (P<0.05; Figure 4A ). Next, we measured neutrophil content within lesions. We observed that the content of Ly6G-positive neutrophils in Apoe −/− mice fed a high-fat Western diet for 14 weeks is markedly (but not completely) less when compared with Apoe −/− mice fed a high-fat Western diet for 4 weeks (not shown). However, it was still possible to quantify Ly6G-positive cells among all groups. The accumulation of Ly6G-positive cells was comparable between 
ADAMTS13
−/− mice when compared with WT or EC-VWF mice, it was not statistically significant ( Figure 5 ). Together, these results suggest that EC-VWF by promoting vascular inflammation contributes to atherosclerosis exacerbation.
EC-VWF, But Not Plt-VWF, Promotes Platelet and Leukocyte Adhesion to Activated Endothelium of Apoe −/− Mice
Platelets are known to recruit leukocytes and play a key role in the onset and progression of atherosclerosis. 23, 24 To define the relative contribution of Plt-VWF versus EC-VWF pool in recruiting quiescent platelets and leukocytes in vivo, we quantified platelet and leukocyte adhesion under the inflammatory condition at the arterial shear rate. Chimeric mice fed a chow diet were challenged with tumor necrosis factor, and the common carotid artery and carotid bifurcation (atheroprone) were visualized for platelet and leukocyte adhesion after 3.5 hours by intravital microscopy. We found that the number of adherent platelets (adherent for >30 seconds) and leukocytes were comparable between Plt-VWF-KO, VWF-KO, and Plt-VWF/ ADAMTS13 −/− mice but significantly decreased when compared with WT or EC-VWF mice ( Figure 6 ). The number of adherent platelets and leukocytes were comparable between WT and EC-VWF mice. These results suggest that EC-VWF, but not Plt-VWF, contributes to platelet and leukocyte adhesion under inflammatory conditions.
Discussion
The results presented herein provide novel insights on the relative importance of different pools of VWF in the pathophysiology of atherosclerosis. The key findings of the study are (1) EC-VWF, but not Plt-VWF, contributes to VWF-dependent atherosclerosis most likely by promoting platelet adhesion and vascular inflammation. (2) Plt-VWF even in the absence of ADAMTS13 in the platelets and plasma was not able to promote atherosclerosis.
The first evidence on the role of VWF in atherosclerosis was demonstrated in 1978 using pigs with von Willebrand's disease (VWD). 17 These findings were further confirmed at the genetic level using either Vwf 
Apoe
−/− mice, 9,12 suggesting a protective effect of complete VWF deficiency in atherosclerotic lesion development. However, the relative contribution of different pools of VWF in the pathophysiology of atherosclerosis was never investigated. We determined the differential role of Plt-VWF and EC-VWF in the progression of atherosclerosis because of functional differences between them. Although binding affinities to collagen are comparable between Plt-VWF and EC-VWF, Plt-VWF binds with higher affinity to the surface of thrombin-stimulated platelets when compared with EC-VWF. 21, 22 Other studies suggested that Plt-VWF binds efficiently to activated αIIbβ3 and αIIb contributes to atherosclerosis. 22, 23, 25, 26 In contrast, Plt-VWF was demonstrated to be less capable of binding to GPIbα when compared with EC-VWF. 22 We and others have recently found that Plt-VWF contributed to transient thrombus growth in experimental models of thrombosis. 27, 28 Based on these studies, we speculated that Plt-VWF may alone be sufficient to promote atherosclerosis exacerbation. To our surprise, we found that EC-VWF, but not Plt-VWF, solely contributes to atherosclerotic lesion progression in both aorta and aortic sinus. We found that atherosclerotic lesions in the EC-VWF were not only larger but also more inflammatory (increased Ly6G-positive and Mac-3-positive content, increased MMP9 and MMP2 content) associated with the larger necrotic area and reduced interstitial collagen when compared with Plt-VWF mice. Furthermore, we found an increase in chemokine fractalkine (CX 3 CL1) in the lesions of EC-VWF mice when compared with Plt-VWF mice. CX 3 CL1 was shown to mediate platelet adhesion and leukocyte recruitment via endothelial VWF. 29 Together, these studies suggest that EC-VWF, but not Plt-VWF, exacerbate atherosclerosis by promoting vascular inflammation.
VWF deficiency in mice results in a defect in WeibelPalade body formation, which results in lower P-selectin expression and defect in leukocyte recruitment in an experimental model of acute inflammation when fed a chow diet. 30 Is it possible that decreased P-selectin expression in endothelial cells of chimeric Plt-VWF mice, which lack EC-VWF, may mask the effect of Plt-VWF in atherosclerotic lesion development? We think that such a possibility is minimal based on following observations. First, the absence of VWF reduces P-selectin-dependent leukocyte rolling in mesenteric venules of mice fed a chow diet but not an atherogenic diet. 12 This result suggests that increased P-selectin synthesis and direct plasma membrane deposition under atherogenic conditions are less dependent on regulated secretion of Weibel-Palade bodies. 12 Second, immunohistochemical staining of the aortic sinus revealed that P-selectin expression was comparable between EC-VWF and Plt-VWF mice fed a high-fat Western diet for 14 weeks. Third, reduction in the atherosclerotic lesion in P-selectin −/− LDLR −/− mice was not observed in female mice fed a high-fat diet for 8 weeks. 31 Herein, we have used female mice fed a high-fat Western diet for 14 weeks.
Platelets contain ADAMTS13, 20, 32 in addition to ADAMTS13 present in plasma. A previous study suggested that Plt-VWF is resistant to ADAMTS13 cleavage in vitro because of different glycosylation profile. 18 Based on these observations, we speculated that in the absence of ADAMTS13, VWF/ultra large VWF released from platelets might be sufficient to support atherosclerotic lesion progression by promoting leukocyte infiltration. To test this, we transplanted irradiated Vwf 
−/− donors so that VWF released after platelet activation is not cleaved by ADAMTS13. To our surprise, we found that atherosclerotic lesion progression in the aorta and aortic sinus was comparable in Plt-VWF/ADAMTS13
−/− mice to Plt-VWF or VWF-KO mice. Results from these chimeric studies suggest that under physiological conditions Plt-VWF by itself, even in the absence of ADAMTS13, does not contribute to atherosclerosis. Platelets bound to the activated endothelium are known to promote vascular inflammation and thereby play a key role in the pathophysiology of atherosclerosis. 23, 24 We found that EC-VWF, but not Plt-VWF, markedly increased platelet and leukocyte adhesion in atheroprone carotid vessels under inflammatory conditions. These findings are in agreement with other studies, which have shown that EC-VWF released from activated endothelium can recruit quiescent platelets and leukocytes although at low shear rate similar to condition that might occur in the regions of aorta and aortic sinus. 6, 13, 33, 34 Another study showed that quiescent platelets adhere to endothelium via endothelial VWF get activated and can support leukocyte rolling at high shear stress in vitro via leukocyte P-selectin glycoprotein ligand-1 and platelet P-selectin. 35 Activated platelets are known to promote acute inflammation by stimulating endothelium 36 and accelerate atherosclerosis. Several studies suggest that in addition to vascular inflammation, hypercoagulability also contributes to the pathophysiology of atherosclerosis. 37, 38 The possibility that endothelial VWF/platelet interactions may promote atherosclerosis exacerbation by enhancing hypercoagulability, in addition to vascular inflammation, cannot be ruled out.
Despite animal studies that strongly support the role of VWF in atherosclerosis, the evidence of protective effect of VWD in humans is weak. [39] [40] [41] [42] [43] [44] Autopsies showed that patients with VWD were not protected from atherosclerosis. [42] [43] [44] However, patients with more severe hemophilia A or VWD had fewer atherosclerotic plaques compared with patients with less severe coagulopathy. 45 The possibility that patients with VWD have some detectable level of VWF activity in plasma (ristocetin cofactor activity; ≈30-50 IU/dL, whereas the normal range is 50-200 IU/dL) that might be sufficient to promote atherosclerosis cannot be ruled out. We note that there is one study that demonstrated that patients with type 3 severe VWD (completely lack VWF) are not protected from atherosclerosis. However, the overall plaque burden in the study population was <20% most likely because of inclusion of the young subjects (mean age, 35 years). 46 More clinical studies are needed to further clarify the role of VWF in promoting atherosclerosis in humans.
In conclusion, the present study identifies that EC-VWF, but not Plt-VWF, as a key player that promotes atherosclerosis in the aorta and aortic sinus of Apoe −/− mice, a clinical-relevant model of atherosclerosis.
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